GE Capital HFS Agents Amneal Pharmaceuticals Financing
GE Capital, Healthcare Financial Services announced that it is serving as administrative agent and collateral agent on a $250 million term loan financing for Amneal Pharmaceuticals. This term loan will be pari passu with a previously closed $491 million term loan on which GE Capital is also the administrative agent. GE Capital Markets served as joint bookrunner on both financings.
Bridgewater, NJ-based Amneal is a vertically-integrated developer, manufacturer, marketer and distributor of generic pharmaceuticals.
“We value our long-standing relationship with HFS and its deep understanding of our company and our business,” said Rochelle Fuhrmann, Amneal’s CFO. “We’re pleased with its focus and execution as well as its ability to handle the many dynamics that come into play on large financing deals.”
“We are pleased to have completed this financing for Amneal. It’s the sixth transaction we’ve successfully agented for the company over the past several years,” said Al Aria, senior managing director of HFS’ Corporate Finance business. “It further illustrates our ability to combine our pharmaceutical sector expertise with our capital markets capabilities to help rapidly growing companies such as Amneal realize their strategic goals.”